Reimann B Y, Zell R, Kandolf R
Max-Planck-Institut für Biochemie, Martinsried, Federal Republic of Germany.
J Virol. 1991 Jul;65(7):3475-80. doi: 10.1128/JVI.65.7.3475-3480.1991.
A neutralizing antigenic site of coxsackievirus B4 (CVB4) was identified by construction of an antigen chimera between coxsackievirus B3 (CVB3) and CVB4. This chimera, designated CVB3/4, was constructed by inserting five amino acids of the putative BC loop of the structural protein VP1 of CVB4 into the corresponding loop of CVB3 by site-directed mutagenesis of infectious recombinant CVB3 cDNA. The chimeric cDNA was capable of inducing an infectious cycle upon transfection of permissive host cells. The resulting chimeric virus CVB3/4 was neutralized and precipitated by CVB4 and CVB3 serotype-specific polyclonal antisera, demonstrating that it unifies antigenic properties of both coxsackievirus serotypes. In addition, the chimera elicited antibodies in rabbits which were capable of neutralizing the two coxsackievirus serotypes CVB3 and CVB4. The insertion of the CVB4-specific antigenic site into the BC loop of CVB3 reduces the efficiency of viral replication, resulting in a small-plaque morphology of the virus chimera. In summary, these data give evidence for the presence of a serotype-specific neutralizing antigenic site in the BC loop of VP1 of CVB4 (amino acids 81 to 89). Our findings suggest that the construction of intertypic chimeras can be used as a tool for the identification of antigenic sites of coxsackieviruses. The retained immunogenicity of the mapped CVB4-specific antigenic epitope, when expressed in CVB3, indicates that CVB3 can be used as a RNA virus vector for heterologous antigenic sites.
通过构建柯萨奇病毒B3(CVB3)和柯萨奇病毒B4(CVB4)之间的抗原嵌合体,鉴定出了CVB4的一个中和抗原位点。这种嵌合体命名为CVB3/4,是通过将CVB4结构蛋白VP1假定的BC环的五个氨基酸,通过感染性重组CVB3 cDNA的定点诱变插入到CVB3的相应环中构建而成。嵌合cDNA在转染允许性宿主细胞后能够引发感染周期。产生的嵌合病毒CVB3/4被CVB4和CVB3血清型特异性多克隆抗血清中和并沉淀,表明它兼具两种柯萨奇病毒血清型的抗原特性。此外,该嵌合体在兔体内引发的抗体能够中和两种柯萨奇病毒血清型CVB3和CVB4。将CVB4特异性抗原位点插入CVB3的BC环会降低病毒复制效率,导致病毒嵌合体呈现小斑块形态。总之,这些数据证明CVB4的VP1的BC环(氨基酸81至89)中存在血清型特异性中和抗原位点。我们的研究结果表明,构建型间嵌合体可作为鉴定柯萨奇病毒抗原位点的工具。在CVB3中表达时,所定位的CVB4特异性抗原表位保留的免疫原性表明,CVB3可作为异源抗原位点的RNA病毒载体。